local_hospital

Vitos Orthopaedische Klinik Kassel gGmbH

Address
lock Available on a paid plan

Nervous System Diseases and Migraine Research

At Vitos Orthopaedische Klinik Kassel gGmbH, the clinical trial portfolio focuses on nervous system diseases with a strong emphasis on migraine. The studies explore both long-term prevention and acute symptom relief for people living with chronic migraine and episodic migraine.

  • Evaluating new approaches for preventing migraine attacks in adults with chronic or episodic forms of the condition.
  • Comparing treatments for the acute management of migraine pain and related symptoms.
  • Assessing whether therapies can reduce the number of monthly migraine days and improve everyday functioning.

This research is aimed at improving both the effectiveness and tolerability of migraine care, with studies that may help refine treatment options for patients who need better prevention or faster relief.

Chronic Migraine Treatment Studies

One major area of research at this hospital clinic is chronic migraine, where trials are testing therapies designed to lower the burden of frequent headache days. The goal is to determine whether these treatments can provide meaningful prevention for patients experiencing persistent migraine symptoms.

  • Testing preventive treatment options for people with chronic migraine.
  • Measuring reductions in monthly migraine days as an indicator of benefit.
  • Studying safety and tolerability alongside symptom control.

These studies help build evidence for better long-term management of migraine attacks with or without aura, especially for patients who need ongoing preventive care.

Episodic Migraine and Acute Relief Research

The site also conducts trials in episodic migraine, focusing on treatments that may improve how quickly and effectively migraine symptoms are relieved. Research here examines whether new options can ease pain during attacks and support patients who are unsuitable for standard therapies.

  • Evaluating treatments for the acute relief of migraine headache pain.
  • Comparing active therapy with placebo to measure symptom improvement.
  • Exploring care options for adults with migraine with or without aura.

This work is intended to strengthen the evidence base for more flexible migraine treatment strategies, balancing symptom control with practical use in everyday clinical care.

Preventive Migraine Therapy and Long-Term Care

Research at the Kassel site includes studies of preventive therapies for both chronic and episodic migraine. These trials are designed to assess whether treatment can reduce attack frequency over time while remaining safe and well tolerated.

  • Investigating long-term prevention of migraine episodes.
  • Studying the impact of therapy on monthly headache burden.
  • Generating evidence to support improved preventive care for migraine patients.

The focus on prevention reflects an effort to improve quality of life for people affected by recurring neurological symptoms and to expand treatment choices in a common headache disorder.

Site Overview

assignment
5
connected trials
corporate_fare
4
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
5
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
4
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
5
Outperforms 72% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
4sponsors
Outperforms 71% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Vitos Orthopaedische Klinik Kassel gGmbH

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled StudyIpsen InnovationPhase IIINot RecruitingMar 2024

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins2Unknown2025-10-062025-10-06

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.